Skip to main content
PFSA
NASDAQ Industrial Applications And Services

Profusa Issues $714K Convertible Note and Exchanges $6.1M Debt for Preferred Stock

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$5.41
Mkt Cap
$3.307M
52W Low
$3.223
52W High
$5,190.014
52W Position info
68% above low
Off High info
100% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

PFSA sits 68% above its 52-week low of $3.223.

Summary

Profusa raised $650K via a new convertible note and exchanged $6.1M of existing debt for preferred stock, providing liquidity but adding dilution and debt obligations.


Key Events · Financing and Capital Events · PFSA

  • New Convertible Note Issued

    Profusa issued a $714,285.72 senior secured convertible note to Ascent Partners Fund LLC for $650,000 cash, with 7% interest and a conversion price of $1.07 per share.

  • Debt Exchange Agreement

    The company agreed to exchange $6,137,958.66 of existing notes for Series A Non-Voting Convertible Preferred Stock at an effective conversion price of $4.28 per share, tied to the G3 Vision Labs option closing.

  • Warrant Exercise Price Reduced

    Amendment No. 5 reduced the exercise price of a warrant issued to Ascent on April 20, 2026, to $1.07 per share, subject to further adjustment.

  • Mandatory Prepayment Obligation

    The new note requires a mandatory prepayment of 33% of net proceeds from any subsequent offering, and monthly amortization payments begin December 1, 2026.


Analysis · PFSA · Industrial Applications And Services

Profusa raised $650,000 in cash through a new senior secured convertible note with a 7% interest rate and a conversion price of $1.07 per share, while simultaneously restructuring $6.1 million of existing debt into preferred stock at an effective conversion price of $4.28 per share. The new note carries an original issue discount, monthly amortization starting December 2026, and a mandatory prepayment of 33% of net proceeds from any future offering. The exchange agreement is tied to the closing of the G3 Vision Labs option, and the preferred stock automatically converts to common stock shortly after issuance. Given the company's going concern doubts and cash balance of only $0.7 million as of the last 10-Q, this financing provides near-term liquidity but adds significant dilution and debt service obligations.

At the time of this filing, PFSA was trading at $5.41 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.3M. The 52-week trading range was $3.22 to $5,190.01. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PFSA - Latest Insights

PFSA
Aug 20, 2026, 8:32 AM EDT
Filing Type: 8-K
Importance Score:
8
PFSA
Aug 20, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
PFSA
Aug 19, 2026, 8:15 PM EDT
Filing Type: 4
Importance Score:
7
PFSA
Aug 19, 2026, 8:14 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
PFSA
Aug 19, 2026, 8:13 PM EDT
Filing Type: 4
Importance Score:
7